Yu M, Nah GSS, Krishnan V, Sulaimi FNB, et al. The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies. Leukemia 2024 Oct 22. doi: 10.1038/s41375-024-02418.
PMID: 39438588